Key hire
Global X ETFs appoints Scott Spencer as Head of Marketing
Global X ETFs has hired marketing veteran Scott Spencer as its Head of Marketing to drive its brand as the Australian ETF issuer expands its product range.
Company
CommSec
Funding history
Investors
Every investor coverage indicates participated in a round CommSec raised.
What CommSec bought
Companies CommSec acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
People
| Name | Role | Sources |
|---|---|---|
| Paul Rayson | MD (former) | Startup Daily |
| Rod Bristow | Chief Operating Officer and Alternate MD (former) | Breakthrough Victoria (Tue 9 Sep 2025), Breakthrough Victoria (Fri 21 Mar 2025), Startup Daily |
Coverage
Stories naming CommSec. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
News
From Vision to Impact: How Breakthrough Victoria Is Powering the State’s Innovation Economy
Breakthrough Victoria's CEO sets out the fund's investment record and an EY report finding its portfolio delivers strong returns and economic impact for Victoria.
Fund close
$100m
Thought Leadership Series: A CEO's Perspective on Driving Innovation
Breakthrough Victoria's chief executive reflects on the sovereign fund's first four years, its university co-funding partnerships and OECD evidence that government venture capital works best alongside private investors.
2 deals
US-listed analytics company Alteryx buys Sydney AI startup Hyper Anna
Analytics automation firm Alteryx has acquired Sydney AI startup Hyper Anna on undisclosed terms. The article recalls Hyper Anna's 2016 seed round and 2017 Series A backed by Sequoia China, Airtree, Reinventure and IAG Firemark.
2 deals
Pathzero raises $6.8 million to improve carbon transparency
Sydney carbon-emissions platform Pathzero raised US$5 million (A$6.8m), led by Carthona Capital with Antler Australia and angel backers, to fund global expansion, after a $1 million seed round a year earlier.
Also Startup Daily·Startup Daily·SmartCompany·TechCrunch Venture
Funding announcement
CEO Dr James Garner interviewed for CommSec's Executive Series
Kazia Therapeutics' chief executive discussed the biotech's recent four-million-dollar raise, ovarian cancer trial data, and a trans-Tasman award win during an interview in CommSec's executive series.